Assists organ procurement organization and transplant hospital staff to submit data to CORR.
Reference manuals on submitting data to CORR, for staff at organ procurement organizations, transplant hospitals and hospitals providing renal replacement therapy.
This document summarizes the strengths and limitations of the nursing data contained in our analytical products and the ways in which it can be effectively used and analyzed.
Summarizes the strengths and limitations of the health workforce data contained in our analytical products and the ways in which it can be effectively used and analyzed.
2016 Summary Statistics, January 1 to December 31, 2016
Topics that supplement the tables and figures: CORR board of directors; list of transplant hospitals, renal programs and organ procurement organizations; glossary and acronyms; analytical methods; and primary diagnoses captured by CORR.
Take a closer look at donors, both living and deceased, trends over the last decade, relationships to transplant recipients and donor rates across Canada.
Trends for lung, heart, liver, pancreas (including islet cell) and intestinal transplant recipients, patients on waiting lists and patient outcomes.
Annual release of data from the Canadian Organ Replacement Register (CORR), including statistics on dialysis, organ transplantation and donation characteristics, trends and patient outcomes in Canada between 2007 and 2016.
Pre-formatted tables providing incidence, prevalence and 5-year survival rates for end-stage kidney disease patients in Canada, by diabetes status and body mass index.
Pre-formatted tables providing 5-year survival rates for kidney transplant patients in Canada, with or without diabetes.
Trends for end-stage kidney disease (ESKD) patients who are newly diagnosed (incidence), patients on treatment (prevalence), patient outcomes (survival), kidney transplant recipients and patients on waiting lists.
Information on the types of data captured in CORR, data supply chain, coverage, under-reporting, non-response, reliability/response bias, methodological changes and revision history.
Information about recent and upcoming CIHI releases, as well as new and notable initiatives from our partners.
CIHI is committed to providing key data on prescription opioids — which include commonly known types such as fentanyl, oxycodone, morphine, codeine and hydromorphone — through a variety of reports and programs.
The overall amount of opioids Canadians are getting in prescriptions is dropping, while the number of prescriptions for the drugs is rising amid the opioid crisis, new CIHI data shows.
How much do Canadians spend on drugs? Learn more about prescribed drug spending at a glance.
Methodology information to help users better understand and interpret the analysis in the Prescribed Drug Spending in Canada report.
Top 100 drug classes in terms of public drug program spending and rate of use for 9 provinces, 1 territory and 1 federal program.
International comparisons of pharmaceutical spending using data from the Organisation for Economic Co-operation and Development.